Stay updated on Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.

Latest updates to the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page
- Check7 days agoChange DetectedMantua, Italy was added to the list of locations and Mantova, Italy was removed.SummaryDifference0.0%

- Check14 days agoChange DetectedAdded the MeSH term 'Severe myoclonic epilepsy in infancy' to the Additional Relevant MeSH Terms on the study record.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved 'Dravet syndrome' from the list of conditions in the study details, affecting how the study's scope and eligibility are described.SummaryDifference0.0%

- Check29 days agoChange DetectedAdded a new revision notice 'Revision: v3.5.0' and removed the previous 'Revision: v3.4.3'.SummaryDifference0.1%

- Check36 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check43 days agoChange Detected- No visible additions or deletions; the page content and layout appear unchanged between the two screenshots.SummaryDifference0.1%

Stay in the know with updates to Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ZX008 in Epileptic Encephalopathy Clinical Trial page.